Holen Sie sich die Stockscreener-App
20.60
0.41%
-0.1025
Schlusskurs vom Vortag:
$20.70
Offen:
$20.39
24-Stunden-Volumen:
34,195
Relative Volume:
1.21
Marktkapitalisierung:
$339.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.12%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$20.25
$21.87
1-Wochen-Bereich:
$19.93
$22.42
52-Wochen-Spanne:
$16.38
$22.69
Claritev Corp Stock (CTEV) Company Profile
Firmenname
Claritev Corp
Sektor
Branche
Telefon
212-780-2000
Adresse
7900 TYSONS ONE PLACE, MCLEAN
Vergleichen Sie CTEV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
20.61 | 339.04M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
226.94 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.78 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.08 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.68 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.08 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-26 | Eingeleitet | Piper Sandler | Neutral |
| 2022-12-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-07-12 | Eingeleitet | Goldman | Neutral |
| 2021-10-04 | Fortgesetzt | Citigroup | Buy |
| 2021-04-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-19 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Claritev Corp Aktie (CTEV) Neueste Nachrichten
Read the Document: Trump's DOJ Supports Antitrust MDL Alleging Health Care Price-Fixing Conspiracy - Law.com
DOJ backs up providers in suit against Claritev - Yahoo Finance
MultiPlan Extends $100 Million Stock Buyback -November 08, 2023 at 09:41 am EST - Marketscreener.com
Little Excitement Around Claritev Corporation's (NYSE:CTEV) Revenues As Shares Take 28% Pounding - simplywall.st
MultiPlan Earns 2023 Great Place to Work Certification™ - Business Wire
Claritev Taps TBA Worldwide’s Brandon as Agency of Record - citybiz
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks - BioSpace
Claritev corp EVP and CFO Garis buys $175,890 in stock By Investing.com - Investing.com Australia
Multiplan Corporation Provides Earnings Guidance for Fourth Quarter 2023 and Revises Earnings Guidance for the Full Year 2023 - Marketscreener.com
Claritev Corp CEO Dalton Travis purchases $100,822 in stock By Investing.com - Investing.com South Africa
Claritev Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Claritev corp EVP and CFO Garis buys $175,890 in stock - Investing.com
Piper Sandler raises Claritev stock target to $19 from $10 - Investing.com India
Piper Sandler raises Claritev stock target to $19 from $10 By Investing.com - Investing.com South Africa
Claritev Corp announces executive compensation changes - Investing.com
New York health-tech company Claritev moves headquarters to Northern Virginia - The Business Journals
Claritev to Release Investor Presentation on March 2025 - TipRanks
MultiPlan Corporation completed the acquisition of Discovery Health Partners. -February 25, 2021 - Marketscreener.com
Transcript : MultiPlan Corporation Presents at Bank of America Securities 2023 Leveraged Finance Conference, Nov-28-2023 08 - Marketscreener.com
MultiPlan Corporation will Change its Ticker to CTEV from MPLN -February 28, 2025 at 12:00 am EST - Marketscreener.com
Claritev Corp SEC 10-K Report - TradingView
Claritev’s 2024 Financial Results and 2025 Outlook - TipRanks
Citi raises Multiplan stock price target to $21, keeps neutral rating By Investing.com - Investing.com South Africa
Citi raises Multiplan stock price target to $21, keeps neutral rating - Investing.com
Earnings call transcript: Claritev's mixed Q4 2024 results prompt market drop - Investing.com
Claritev Corporation Reports Fourth Quarter and Full Year 2024 Results - TradingView
Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025 - Business Wire
Claritev Corporation (MPLN): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
Claritev Corp announces strategic transformation program - Investing.com India
12 Best Performing Small Cap Stocks So Far in 2025 - Insider Monkey
Multiplan Corporation Announces That Carol Nutter Has Joined the Company as Chief People Officer - Marketscreener.com
Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design - 01Net
Claritev Provides Oracle Cloud HCM Customers With Actionable Insights For Healthcare Cost Optimization And Plan Design - Marketscreener.com
Can This New Oracle-Powered Solution Solve the Healthcare Cost Crisis for Enterprises? - Stock Titan
MultiPlan Rebrands to Claritev, Shifts Strategic Focus - TipRanks
MultiPlan shifts direction, changes name to Claritev - Modern Healthcare
Multiplan Corp Corporate Rebrand To Claritev -February 17, 2025 at 06:45 am EST - Marketscreener.com
MultiPlan changing name to Claritev, ticker symbol to ‘CTEV’ - TipRanks
MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call - Business Wire
MultiPlan Announces Expiration and Results of Exchange Offers and Consent Solicitations for Outstanding Notes and Term Loans with Over 99% Participation of Existing Noteholders and Lenders - Business Wire
MultiPlan Selects Oracle Cloud Infrastructure to Power its Business Transformation - Business Wire
MultiPlan and J2 Health Announce Strategic Agreement to Enhance Network Services and Analytics - Business Wire
MultiPlan Inks Deal With Creditors to Refinance $4.5 Billion - Bloomberg
MultiPlan Announces Comprehensive Refinancing - Business Wire
CompleteVue™ – MultiPlan’s new Pricing Analytics Solution that Empowers Healthcare Providers - Business Wire
MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance - Business Wire
MultiPlan Accepting Applications for Rural Health Grant - Business Wire
MultiPlan Appoints Tiffani Misencik to Drive Strategic Growth - Business Wire
MultiPlan Corporation Announces Third Quarter 2024 Earnings Conference Call - Business Wire
MultiPlan Announces Executive Leadership Changes - Business Wire
MultiPlan and the National Rural Health Association Announce Strategic Alliance to Empower Rural Healthcare Providers through Innovative Technology and Services - Business Wire
Finanzdaten der Claritev Corp-Aktie (CTEV)
Es liegen keine Finanzdaten für Claritev Corp (CTEV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
3.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):